1
|
t1pks
|
1
|
4
|
–
|
Narbonolide/10-deoxymethynolide (pikAI – AIV), Phthiocerol/phenolphthionocerol (ppsA - E)
|
–
|
**
|
2
|
t1pks
|
2
|
–
|
–
|
Phthiocerol/phenolphthionocerol (ppsA - E)
|
–
|
–
|
3
|
t1pks
|
18
|
19
|
7
|
Azaphilone*, Lovastatin (LOVB, LOVF), Narbonolide/10-deoxymethynolide (pikAI – AIV), Phthiocerol/phenolphthionocerol (ppsA - E)
|
–
|
–
|
4
|
t1pks
|
22
|
–
|
–
|
–
|
–
|
*
|
5
|
t1pks
|
23
|
48
|
17
|
Lovastatin (LOVB, LOVF), Narbonolide/10-deoxymethynolide (pikAI – AIV), Phthiocerol/phenolphthionocerol (ppsA - E)
|
–
|
*
|
6
|
t1pks
|
19
|
43
|
–
|
Monacolin K*, Compactin, Lovastatin (LOVA, LOVB)
|
–
|
*
|
7
|
t1pks
|
–
|
–
|
8
|
Citrinin*, Narbonolide/10-deoxymethynolide (pikAI–AIV), Phthiocerol/phenolphthionocerol (ppsA-C, E)
|
–
|
*
|
8
|
t1pks
|
9
|
–
|
10
|
Byssochlamic acid*, Narbonolide/10-deoxymethynolide (pikAI–AIV), Phthiocerol/phenolphthionocerol (ppsA-C, E)
|
–
|
*
|
9
|
nrps
|
4
|
10
|
19
|
Neosartoricin*, Fengycin (fenA–E), Surfacin (srfAA-AC)
|
–
|
**
|
10
|
nrps
|
13
|
30
|
20
|
Brevianamide F (FTMA)
|
ABCB
|
**
|
11
|
nrps
|
7
|
2
|
–
|
Fengycin (fenA-E), Surfacin (srfAA-AC)
|
ABCC
|
**
|
12
|
nrps
|
11
|
23
|
2
|
Fengycin (fenA-D)
|
ABCC
|
**
|
13
|
nrps
|
5
|
22
|
12
|
Fengycin (fenA-D)
|
–
|
*
|
14
|
nrps
|
24
|
21
|
–
|
Fengycin (ppsA-D), surfacing (srfAA-AC)
|
ABCB
|
*
|
15
|
nrps
|
3
|
41
|
–
|
Fengycin (fenA–D)
|
–
|
*
|
16
|
nrps
|
–
|
–
|
9
|
Fengycin (fenB, D), Ferricrocin (SIDC, SIDD)
|
–
|
–
|
17
|
t1pks-nrps
|
8
|
40
|
5
|
NG-391*, Fengycin (fenA–E), Surfacin (surAA-AC)
|
ABCC
|
**
|
18
|
t1pks-nrps
|
14
|
27
|
14
|
Gramicidin (grsA-B), Fengycin (fenA–E), Surfacin (surAA-AC)
|
–
|
*
|
19
|
t1pks-nrps
|
20
|
13
|
3
|
Lovastatin (LOVB, LOVF), Fengycin (fenA-E), Surfactin (srfAA-AC)
|
ABCB
|
*
|
ID
|
Type of GCs
|
Pi
|
Ru
|
Pu
|
Secondary metabolic pathways detected in DNA sequence homology
|
ATP-binding cassettes
|
Identity level
|
20
|
terpene
|
12
|
24
|
11
|
Fernesyl-diphosphate (FDFT1)
|
–
|
**
|
21
|
terpene
|
17
|
12
|
13
|
Lupeol (LUP1,2,4,5), Arabidiol (PEN1), Tinucalladienol (PEN3), seco-amyrin (PEN6)
|
–
|
*
|
22
|
terpene
|
–
|
–
|
15
|
–
|
–
|
–
|
23
|
others
|
15
|
42
|
18
|
Fengycin (fenA, C, E), Surfacin (srfAA-AB)
|
ABCF
|
**
|
24
|
others
|
6
|
32
|
6
|
Kinesin (KIDFC1–3)
|
–
|
*
|
25
|
others
|
10
|
5
|
16
|
Abscisic aldehyde (AAO1–4), Fengycin (fenA, B, E), Surfactin (srfAA, AB)
|
ABCB
|
*
|
26
|
others
|
16
|
33
|
4
|
Histidinol (hisD, IE)
|
–
|
*
|
27
|
others
|
21
|
28
|
1
|
–
|
–
|
*
|
28
|
cf-putative
|
–
|
1
|
–
|
–
|
–
|
–
|
29
|
cf-putative
|
–
|
3
|
–
|
Palmitin (ZDHHC)
|
–
|
–
|
30
|
cf-putative
|
–
|
6
|
–
|
Palmitin (ZDHHC4)
|
–
|
–
|
31
|
cf-putative
|
–
|
7
|
–
|
–
|
–
|
–
|
32
|
cf-putative
|
–
|
8
|
–
|
–
|
–
|
–
|
33
|
cf-putative
|
–
|
9
|
–
|
–
|
–
|
–
|
34
|
cf-putative
|
–
|
11
|
–
|
–
|
–
|
–
|
35
|
cf-putative
|
–
|
14
|
–
|
Serine, Threonine (PP1C, 2C, 4C, 6C)
|
–
|
–
|
36
|
cf-putative
|
–
|
15
|
–
|
–
|
ABCG2
|
–
|
37
|
cf-putative
|
–
|
16
|
–
|
–
|
–
|
–
|
38
|
cf-putative
|
–
|
17
|
–
|
–
|
–
|
–
|
39
|
cf-putative
|
–
|
18
|
–
|
Mannan (ANPI, MNN9)
|
–
|
–
|
40
|
cf-putative
|
–
|
20
|
–
|
–
|
–
|
–
|
41
|
cf-putative
|
–
|
25
|
–
|
–
|
–
|
–
|
42
|
cf-putative
|
–
|
29
|
–
|
–
|
–
|
–
|
43
|
cf-putative
|
–
|
31
|
–
|
–
|
–
|
–
|
44
|
cf-putative
|
–
|
34
|
–
|
–
|
–
|
–
|
45
|
cf-putative
|
–
|
36
|
–
|
–
|
–
|
–
|
ID
|
Type of GCs
|
Pi
|
Ru
|
Pu
|
Secondary metabolic pathways detected in DNA sequence homology
|
ATP-binding cassettes
|
Identity level
|
46
|
cf-putative
|
–
|
37
|
–
|
–
|
–
|
–
|
47
|
cf-putative
|
–
|
38
|
–
|
–
|
–
|
–
|
48
|
cf-putative
|
–
|
39
|
–
|
Lovastatin (LOVB-G), Phthiocerol/Phenolphthiocerol (ppsA,C)
|
–
|
–
|
49
|
cf-putative
|
–
|
44
|
–
|
–
|
–
|
–
|
50
|
cf-putative
|
–
|
45
|
–
|
–
|
–
|
–
|
51
|
cf-putative
|
–
|
46
|
–
|
–
|
–
|
–
|
52
|
cf-putative
|
–
|
47
|
–
|
–
|
–
|
–
|
53
|
cf_fatty_acid
|
–
|
26
|
–
|
–
|
–
|
–
|
54
|
cf_fatty_acid
|
–
|
35
|
–
|
Fatty acid (FAS1,2)
|
–
|
–
|